| Literature DB >> 7599291 |
M J Starmans-Kool1, M M Fickers, M A Pannebakker.
Abstract
A patient with idiopathic myelofibrosis is reported who developed a drug fever after treatment with hydroxyurea, a generally effective and well-tolerated drug in chronic myeloproliferative syndromes. Typically, this form of fever develops after a few weeks of exposure to the drug and disappears with discontinuation of the drug. Possible interactions with prostaglandin or leukotriene metabolism may play a role.Entities:
Mesh：
Substances：
Year: 1995 PMID： 7599291 DOI： 10.1007/BF01784049
Source DB: PubMed Journal: Ann Hematol ISSN： 0939-5555 Impact factor: 3.673